P53 overexpression as an indicator of overall survival and response to treatment in osteosarcomas (original) (raw)

References

1. Brunat-MentignyM and KohlerR: L’osteosarcome. Rev Prat 43: 2197–203, 1993.
   PubMed CAS Google Scholar
2. Cattoretti G, Becker GM, KeyG, et al: Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIBI and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. Journal of Pathology 168: 357–363, 1992.
   Article PubMed CAS Google Scholar
3. Chang F. Syrjanen S. Tervahauta A, and SyrjanenK: Tumourigenesis associated with the p53 tumor suppressor gene. Br J Cancer 68: 653–61, 1993.
   PubMed CAS Google Scholar
4. Cordon-Cardo C, Lettres E, DrohnjakM, et al: Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res 54: 794–9, 1994.
   PubMed CAS Google Scholar
5. Cotran RS, et al: Neoplasia. In Cotran RS, Kumar V, Robbins SL, (eds.): Robbins Pathologic Basis of Disease. Philadelphia, WB. Saunders Company, 1989, pp. 239–305.
   Google Scholar
6. Enneking WF, Spanier SS, Goodman MA: A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop 153: 106, 1980.
   PubMed Google Scholar
7. Fanner G, Bargonetti J, ZlutH, et al: Wild-type p53 activates transcription in vitro. Nature 358: 83–86, 1992.
   Article Google Scholar
8. Friedman JM and McGillivrayB: Genetic Paradigms in Human Disease. In Friedman JM, et al. (eds.): Genetics. Baltimore, Williams & Wilkins, 1992, pp. 130–4.
   Google Scholar
9. Grundmann E, Veda Y Schneider-StockR, and RoessnerA: New aspects of cell biology in osteosarcoma. Pathol Res Pract 191:563–70, 1995.
   PubMed CAS Google Scholar
10. Haines DS, Landers JE, Engle LJ, and George DL: Physical and functional interaction between wild-type p53 and mdm2 proteins. Mol Cell Biol 14:1171–8, 1994.
    PubMed CAS Google Scholar
11. Hall PA and Lane DP: P53 in tumour pathology: can we trust immunohistochemistry? -Revisited!. Journal of Pathology 172:1–4, 1994.
    Article CAS Google Scholar
12. Hanna E, Bodrogi I, InstitorisE, and BakM: A p53 expresszió és a klinikai rezisztencia összefüggésének vizsgálata hererákokban. Orvosi Hetilap 137: 59–64, 1996. (In Hungarian only)
    PubMed CAS Google Scholar
13. HungJ and AndersonR: p53 functions, mutations and sarcomas. Acta Orthop Scand 273: 68–73, 1997
    CAS Google Scholar
14. Isfort RJ, Cody DB, LovellG, and Doersen CJ: Analysis of oncogenes, tumor suppressor genes, autocrine growth-factor production, and differentiation state of human osteosarcoma cell lines. Mol Carcinog 14: 170–8, 1995.
    Article PubMed CAS Google Scholar
15. Knudson AG: Antioncogenes and human cancer. Proc Natl Acad Sci USA 90: 10914–21, 1993.
    Article PubMed CAS Google Scholar
16. KopperL and SehestyenA: P53 (egy molekula, mely „végigsöpört” a daganat kutatáson). Magyar Onkologia 39: 159- 164, 1995. (In Hungarian only)
    Google Scholar
17. Lee JM, Ahrahamson JLA, KandelR, et al: Susceptibility to radiation-carcinogenesis and accumulation of chromosomal breakage in p53 deficient mice. Oncogene 9: 3731–3736, 1994.
    PubMed CAS Google Scholar
18. Levine AJ, Momand J, and Finlay CA: The p53 tumor suppressor gene. Nature 351: 453–456, 1991.
    Article PubMed CAS Google Scholar
19. Lipponen PK: Over-expression of p53 nuclear oncoprotein in transitional- cell bladder cancer and its prognostic value. Int J Cancer 53: 465–470, 1993.
    Google Scholar
20. Malawer M, Link M, and DonaldsonS: Sarcomas of Bone. In Devita V, Hellman S, RosenbergS (eds.): Cancer Principles and Practice of Oncology. Philadelphia, J.B. Lippincott Co., 1993, pp. 1509–1552.
    Google Scholar
21. Nishikawa T, Yamamoto T, MizunoK, et al: Expression of the p53 protein in human osteosarcoma. Nippon Seikeigeka Gakkai Zasshi 68:400–406, 1994.
    PubMed CAS Google Scholar
22. Salzer-Kuntschik M, Delling G, Beron G, SigmundR: Morphological grades of regression in osteosarcoma after poly chemotherapy study COSS 80. J Cancer Res Clin Oncol (Suppl) 106:21, 1983.
    Article PubMed Google Scholar
23. Serra M, Scotlandi K, Manara MC, et al: Establishment and characterization of multi-drug resistant human osteosarcoma cell lines. Anticancer Res 13: 323–9, 1993.
    PubMed CAS Google Scholar
24. Veda Y, Dockhorn-Dworniczak B, BlasiusS, et al: Analysis of mutant P53 protein in osteosarcomas and other malignant and benign lesions of bone. J Cancer Res Clin Oncol 119:172–8, 1993.
    Article Google Scholar
25. WinklerK and BielachS: Chemotherapy of osteosarcoma. Sem Orthop 3: 48–58, 1988.
    Google Scholar

Download references